Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

383.12
Delayed Data
As of Dec 14
 -3.55 / -0.92%
Today’s Change
340.09
Today|||52-Week Range
543.55
+4.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash535.2M811.8M744.3M792.1M
 
 
 
 
 
Short Term Investment Cash-385.2M276.6M-67.5M47.8M
 
 
 
 
 
Cash & Short Term Investments1.0B1.3B1.3B1.4B
 
 
 
 
 
 
ReceivablesReceivables1.6B1.7B1.8B2.0B
 
 
 
 
 
 
InventoriesInventories399.4M466.6M554.3M641.6M
 
 
 
 
 
 
Current AssetsOther Current Assets130.5M146.1M193.3M143.8M
 
 
 
 
 
Current Assets3.2B3.7B3.9B4.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.5B------
 
 
Depreciation-425.5M------
 
 
Other Assets20.3M37.1M37.0M36.6M
 
 
 
 
 
Total Assets7.0B7.8B8.1B8.7B
 
 
 
 
 
 
LiabilitiesAccounts Payable135.0M141.8M151.4M153.9M
 
 
 
 
 
Short Term Debt127.3M7.2M0.000.00
 
 
 
Accrued Expenses355.3M375.1M395.3M371.8M
 
 
 
 
 
Other Current Liabilities590.4M614.4M708.0M692.0M
 
 
 
 
 
Other Liabilities1.2B1.3B1.0B1.1B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt351.6M700.4M701.2M702.3M
 
 
 
 
 
Deferred Taxes-825.3M-866.3M-883.0M-927.0M
 
 
 
 
 
Other Liabilities100.4M106.2M115.9M125.2M
 
 
 
 
 
Total Liabilities2.5B3.0B2.6B2.6B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity4.4B4.9B5.5B6.1B
 
 
 
 
 
Total Shareholder Equity4.4B4.9B5.5B6.1B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding106.0M106.3M107.1M107.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.